Indian scientists have developed a potential 'smart' cancer drug designed to activate inside cancer cells while largely ...
T-cell redirecting platforms function by enabling antigen-specific recognition or by colocalizing effector T cells with tumor ...
By using mRNA molecules to “remodel” parts of the immune system, researchers generated T cells that can slow the growth of ...
Potent drugs like chemotherapy can be life-saving, but often with life-threatening side effects. Notably, they can be indiscriminate, killing both cancer cells and healthy cells in one swoop.
Every encounter between a T cell and a potential target—especially when that target is a developing tumor—begins with a rapid series of molecular decisions. Within seconds, the immune cell must ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and lymphoma. But the immunotherapy has struggled against solid tumors for two ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...
In a Phase 1 trial with six patients, three reached medication-free remission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results